Summary:
In adults with diabetes, individualized HbA1c target-setting (5 mmol/mol higher or lower than current HbA1c) did not significantly impact glycaemic outcomes or patient-reported measures compared to alternate target assignment group, though it was associated with high acceptability and improvements in diabetes distress and self-efficacy.
| PICO | Description |
|---|---|
| Population | Adults with diabetes participating in a randomised feasibility trial evaluating HbA1c target-setting. |
| Intervention | Explicit HbA1c targets set to 5 mmol/mol below participants’ baseline HbA1c levels (Group B). |
| Comparison | HbA1c targets set 5 mmol/mol above participants’ baseline HbA1c levels (Group A). |
| Outcome | No significant between-group differences were found in HbA1c or psychometric outcomes. Across all participants, HbA1c decreased, diabetes-related distress declined, and self-efficacy improved. The target-setting process was deemed acceptable by patients and healthcare professionals. Motivational impact varied depending on goal achievability and perceived relevance. |
Source: Samuel J Westall, et al. “Feasibility of glycated haemoglobin target-setting in adults with diabetes: A mixed-methods study.” Read article here.
